COVID-19 and outcomes in Chinese peritoneal dialysis patients
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · 2024
DOI: 10.1177/08968608231221952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2024. Verfasst von Ruoxi Liao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Kidney Failure, Chronic, Hyponatremia, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Background
Reports on COVID-19 in peritoneal dialysis (PD) patients are scarce in China. This study aimed to describe the characteristics and outcomes of PD patients with COVID-19 after China abandoned the ‘zero-COVID’ policy.
Methods
This single-centre retrospective study included patients receiving PD who underwent testing for COVID-19 infections between 7 December 2022 and 7 January 2023. Outcomes of interest included factors associated with positive COVID-19 testing result and clinical outcomes including COVID-19-related hospitalisation and severe COVID-19, which were analysed using logistic regression analyses.
Results
A total of 349 PD patients (male 53.6%, age 49 ± 13 years old) were included, and 235 patients (67.3%) were infected. There were no significant differences between COVID-19 and non-COVID-19 patients other than higher proportion of vaccinated patients and slow transporters in the patients who tested positive for COVID-19 (44.7% vs. 28.1%, p = 0.003; 8.7% vs. 1.8%, p = 0.03, respectively). Multivariate analysis showed COVID-19 was associated with vaccination (odds ratio (OR): 1.71, 95% confidence interval (CI): 1.02–2.86) and slow transport type (compared with average transport type, OR: 4.52, 95% CI: 1.01–20.21). Among the patients with infection, 38 (16.2%) patients were hospitalised, 18 (7.7%) patients had severe disease and 9 (3.8%) patients died. In multivariate logistic analysis, both age (OR: 1.04, 95% CI: 1.01–1.07; OR: 1.06, 95% CI: 1.02–1.11) and hyponatremia (OR: 5.44, 95% CI: 1.63–18.13; OR: 6.50, 95% CI: 1.77–23.85) were independent risk factors for COVID-19-related hospitalisation and severe disease.
Conclusions
Although vaccinated patients were more likely to have tested positive for COVID-19 infection, they appeared to have less severe infection and less need for hospitalisation. Patients who were older with a history of hyponatremia were more likely to experience adverse outcomes from COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
- Department of Nephrology, West China Xiamen Hospital, Sichuan University, Xiamen, Fujian Province, China.
ORCID-Profile: Ruoxi Liao, Hui Zhong
Zitieren
APA
Liao, R., Zhou, X., Ma, D., Wang, S., Fu, P., & Zhong, H. (2024). COVID-19 and outcomes in Chinese peritoneal dialysis patients. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. https://doi.org/10.1177/08968608231221952
Vancouver
Liao R, Zhou X, Ma D, Wang S, Fu P, Zhong H. COVID-19 and outcomes in Chinese peritoneal dialysis patients. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 2024. doi:10.1177/08968608231221952
BibTeX
@article{Liao2024,
author = {Liao, Ruoxi and Zhou, Xueli and Ma, Dengyan and Wang, Shaofen and Fu, Ping and Zhong, Hui},
title = {COVID-19 and outcomes in Chinese peritoneal dialysis patients},
journal = {Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis},
year = {2024},
doi = {10.1177/08968608231221952}
}
EUVIMED